Jing Pu

InstitutionLindsley F. Kimball Research Institute
AddressNew York
New York
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 8 Covid-19 publications, with a maximum of 2 publications in August 2021 and December 2021
    All Publications
    Bar chart showing 47 publications over 15 distinct years, with a maximum of 7 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Che Y, Liu X, Pu Y, Zhou M, Zhao Z, Jiang R, Yin Z, Xu M, Yin Q, Wang J, Pu J, Zhao H, Zhang Y, Wang L, Jiang Y, Lei J, Zheng Y, Liao Y, Long R, Yu L, Cui P, Yang H, Zhang Y, Li J, Chen W, He Z, Ma K, Hong C, Li D, Jiang G, Liu D, Xu X, Fan S, Cheng C, Zhao H, Yang J, Li Y, Zou Y, Zhu Y, Zhou Y, Guo Y, Yang T, Chen H, Xie Z, Li C, Li Q. Randomized, Double-Blinded, Placebo-Controlled Phase 2 Trial of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in Healthy Adults. Clin Infect Dis. 2021 12 06; 73(11):e3949-e3955. PMID: 33165503.
      Citations: 28     Fields:    Translation:HumansCTClinical Trials
    2. Liao Y, Zhang Y, Zhao H, Pu J, Zhao Z, Li D, Fan S, Yu L, Xu X, Wang L, Jiang G, Liu L, Li Q. Intensified antibody response elicited by boost suggests immune memory in individuals administered two doses of SARS-CoV-2 inactivated vaccine. Emerg Microbes Infect. 2021 Dec; 10(1):1112-1115. PMID: 34057040.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    3. Chen H, Xie Z, Long R, Fan S, Li H, He Z, Xu K, Liao Y, Wang L, Zhang Y, Li X, Dong X, Mou T, Zhou X, Yang Y, Guo L, Yang J, Zheng H, Xu X, Li J, Liang Y, Li D, Zhao Z, Hong C, Zhao H, Jiang G, Che Y, Yang F, Hu Y, Wang X, Pu J, Ma K, Wang L, Cheng C, Duan W, Shen D, Zhao H, Jiang R, Deng X, Li Y, Zhu H, Zhou J, Yu L, Xu M, Yang H, Yi L, Zhou Z, Yang J, Duan N, Yang H, Zhao W, Yang W, Li C, Liu L, Li Q. Immunological evaluation of an inactivated SARS-CoV-2 vaccine in rhesus macaques. Mol Ther Methods Clin Dev. 2021 Dec 10; 23:108-118. PMID: 34462721.
      Citations: 1     
    4. Zhou J, Xu W, Liu Z, Wang C, Xia S, Lan Q, Cai Y, Su S, Pu J, Xing L, Xie Y, Lu L, Jiang S, Wang Q. A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases. Acta Pharm Sin B. 2021 Aug 02. PMID: 34367893.
      Citations:    
    5. Lan Q, Pu J, Cai Y, Zhou J, Wang L, Jiao F, Xu W, Wang Q, Xia S, Lu L, Jiang S. Lipopeptide-based pan-CoV fusion inhibitors potently inhibit HIV-1 infection. Microbes Infect. 2021 Sep-Oct; 23(8):104840. PMID: 34022374.
      Citations:    Fields:    Translation:HumansCells
    6. Pu J, Yu Q, Yin Z, Zhang Y, Li X, Yin Q, Chen H, Long R, Zhao Z, Mou T, Zhao H, Feng S, Xie Z, Wang L, He Z, Liao Y, Fan S, Jiang R, Wang J, Zhang L, Li J, Zheng H, Cui P, Jiang G, Guo L, Xu M, Yang H, Lu S, Wang X, Gao Y, Xu X, Cai L, Zhou J, Yu L, Chen Z, Hong C, Du D, Zhao H, Li Y, Ma K, Ma Y, Liu D, Yao S, Li C, Che Y, Liu L, Li Q. The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18-59 years: A phase I randomized, double-blinded, controlled trial. Vaccine. 2021 05 12; 39(20):2746-2754. PMID: 33875266.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    7. Pu J, Mei H, Lei L, Li D, Zhao J, Li B, Wang H, Ma Y, Du XB. Knowledge of medical professionals, their practices, and their attitudes toward traditional Chinese medicine for the prevention and treatment of coronavirus disease 2019: A survey in Sichuan, China. PLoS One. 2021; 16(3):e0234855. PMID: 33725021.
      Citations: 1     Fields:    Translation:Humans
    8. Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, Zhou Y, Du L. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cell Mol Immunol. 2020 06; 17(6):613-620. PMID: 32203189.
      Citations: 500     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    9. Xia S, Lan Q, Pu J, Wang C, Liu Z, Xu W, Wang Q, Liu H, Jiang S, Lu L. Potent MERS-CoV Fusion Inhibitory Peptides Identified from HR2 Domain in Spike Protein of Bat Coronavirus HKU4. Viruses. 2019 01 14; 11(1). PMID: 30646495.
      Citations: 11     Fields:    Translation:AnimalsCells